HUMAN RNA AND DNA ONCOGENIC VIRUSES AND THEIR IMPORTANCE IN TRANSMISSIBLE AND MALIGNANT DISEASES NLM AIDSLINE Important note: Information in this article was accurate in 1986. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


HUMAN RNA AND DNA ONCOGENIC VIRUSES AND THEIR IMPORTANCE IN TRANSMISSIBLE AND MALIGNANT DISEASES

Dev Oncol; 28:240-6 1985. Unique Identifier : AIDSLINE ICDB/86621739
de The G; Faculty of Medicine Alexis Carrel, Rue G. Paradin 69372 Lyon,; France

Abstract: Human viruses with oncogenic properties are compared from an epidemiological viewpoint and results from the author's sero-epidemiologic studies on human T-cell leukemia virus (HTLV)-I are presented. Genetic, epidemiologic, co-factor, and associated-disease characteristics of the HTLV family, hepatitis B virus, Epstein-Barr virus, and human papilloma viruses 11 and 16 are listed, and data on HTLV-1 antibodies in serum are presented for the French West Indies. Using ELISA, a higher percentage of HTLV-1 was demonstrated in 261 blood donors in Martinique than in 135 blood donors in French Guiana. No typical acquired immune deficiency syndrome (AIDS) cases were found in these places during 1983. Ethnic groups in French Guiana varied in prevalence of HTLV-1 antibodies; the Hmong who emigrated from Kampuchea within the last few yr have become infected with HTLV-1 at approx the same rate as Haitians or Dominican prostitutes (ie, Hmong, 8.8%; Haitians, 5.7%; prostitutes, 9%). (6 Refs)
Keywords: Acquired Immunodeficiency Syndrome/TRANSMISSION DNA Tumor Viruses Human HTLV-BLV Viruses Neoplasms/*TRANSMISSION Retroviridae Risk Tumor Virus Infections/*TRANSMISSION MEETING PAPER

KWDacquiredimmunodeficiencysyndrome/transmissiondnatumorviruseshumanhtlv-blvvirusesneoplasms/KWDtransmissionretroviridaerisktumorvirusinfections/KWDtransmissionmeetingpaper
861130
M86B0249

Copyright © 1986 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1986. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1986. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .